NCV (NCV) Stock Price & Analysis
NCV (NCV) fell 1.14% to USD 16.54 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
NCV last closed at USD 16.73; the session ranged USD 16.49–16.78 on volume of 43,539 shares. Market capitalization is —, with a 52-week range of USD 14.15–17.65 (NYQ). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 16.54 |
|---|---|
| Change | ▼ 1.14% (down) |
| Previous Close | USD 16.73 |
| Open | USD 16.73 |
| Day Range | USD 16.49 – 16.78 |
| 52-Week Range | USD 14.15 – 17.65 |
| Volume | 43,539 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (NCV)
Nexqual's technical model rates NCV "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.41 (neutral) |
| vs SMA50 | Below (USD 17.16) |
| MACD | -0.14 (negative) |
Analyst Ratings (NCV)
Wall Street analysts rate NCV "None", per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (NCV)
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (NCV)
| Total Revenue | $22.36M |
|---|---|
| Revenue Growth (YoY) | -10.50% |
| Gross Margin | +100.00% |
| Operating Margin | +78.50% |
| Profit Margin | +351.06% |
| ROE | +16.48% |
| Debt / Equity | 22.04 |
| Current Ratio | 0.36 |
| Total Cash | $10.73M |
| Total Debt | $109.56M |
| Free Cash Flow | $5.94M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (NCV)
Nexqual rates NCV's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Critical — Revenue -11% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Solid — $11M cash vs $110M debt |
| Cash Flow | Strong — FCF $6M, 27% margin |
| Efficiency | Solid — ROE 16%, ROA 1.9% |
Ownership (NCV)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +29.22% |
| Short % of Float | +0.44% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Major Backers & Investors (NCV)
Notable institutional backers of NCV include Morgan Stanley, Congress Park Capital LLC, Saba Capital Management, L.P., according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 5.77% |
| Congress Park Capital LLC | 3.6% |
| Saba Capital Management, L.P. | 3.2% |
| Advisors Asset Management, Inc. | 2.66% |
| Guggenheim Capital, LLC | 1.85% |
| Penserra Capital Management LLC | 1.68% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 1.67% |
| LPL Financial LLC | 1.64% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NCZ | AllianzGI Convertible & Income | USD 15.17 | ▼ 2.32% |
| PHK | Pimco High Income Fund Pimco Hi | USD 4.62 | ▼ 0.86% |
| CHI | Calamos Convertible Opportuniti | USD 12.64 | ▼ 3.81% |
| IGD | Voya Global Equity Dividend and | USD 6.38 | ▲ 0.31% |
| EAD | 238549 | USD 6.29 | ▼ 1.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.